Navigation Links
Most prescription labels fail to meet guidelines, risking dosage errors
Date:7/9/2014

Small print and poor printing on prescription labels handed out by pharmacists may be misread and may lead to errors in taking medication, according to new research by the University of Waterloo and CNIB (Canadian National Institute for the Blind).

The study, published recently in the Canadian Pharmacists Journal, found that labels on prescription medications dispensed by pharmacies do not consistently follow professionally recommended guidelines for legibility.

By simply following recommended guidelines for font size, use of bolding, justification, sentence case and spacing, researchers expect pharmacies can improve the legibility of their labels without the need for new technologies or larger labels.

"Surprisingly, there are few guidelines and no regulations for the print on prescription labels in Canada," said Dr. Sue Leat from Waterloo's School of Optometry and Vision Science. "In Ontario, regulations specify only the content of prescription labels, not how they appear."

Health professionals and patients are finding label appearance is more important as a significant number of older Canadians experience vision and reading comprehension problems. Patients also prefer to read their own prescriptions to preserve their privacy and independence.

Researchers asked 45 pharmacies in Kitchener, Waterloo and Cambridge to print a sample prescription label with the patient's name, drug name and instructions for use. The sample label was then compared with label printing recommendations from pharmaceutical and health organizations, and non-governmental organizations for readability.

The results show that less than half 44 per cent of labels met the minimum font size of 12 points. Only half of labels were printed left-justified and few met the recommendations for best use of spacing.

All labels used capital lettering, which is difficult for patients with eye problems to read, instead of the recommended sentence case.

More than 90 per cent of labels followed guidelines for font style, contrast, black print and non-glossy paper.

"The research shows that factors such as font size, sentence alignment, case and contrast can impact the readability of the label," said Professor Carlos H. Rojas-Fernandez from Waterloo's School of Pharmacy and a Schlegel Research Chair in Geriatric Pharmacotherapy. "We expect that addressing these factors together will improve the accessibility of prescription labels. We need to move from a pharmacy-centred labelling standard, to a patient-centred one."

This is the first collaborative research project between Waterloo's School of Pharmacy and School of Optometry and Vision Science and was funded by the CNIB Baker Fund.

"CNIB helps thousands of Canadians with vision loss maintain their independence," said Deborah Gold, a study co-author and national director, research and program development at CNIB. "In order to do this and eliminate potentially dangerous medication accidents, we need to raise this issue amongst our colleagues in the pharmacy community."

Recommended guidelines considered in this study came from the US Pharmacopeia (USP), the American Society for Consultant Pharmacists, the National Patient Safety Agency in the UK, the American Foundation for the Blind (AFB), the Canadian National Institute for the Blind (CNIB), the Royal National Institute of Blind People (RNIB) in the UK, and the American Council of the Blind (ACB).

The researchers plan to develop a prototype pharmaceutical label and test its readability and accuracy and use a questionnaire to survey pharmacists and patients (with and without visual impairments).


'/>"/>

Contact: Nick Manning
nmanning@uwaterloo.ca
519-888-4451
University of Waterloo
Source:Eurekalert

Related medicine news :

1. Death by prescription painkiller
2. President Clinton to open town hall on prescription drug abuse at Johns Hopkins University
3. Prescriptions for opioids stabilizing after fivefold increase in 10-year span
4. In fight against teen prescription drug abuse, one-two punch wins
5. Mobile Health Prescription Discount Cards Saved Users 67% in 2013 off Prescription Costs
6. Newark Treatment Center Announces Program to Battle Prescription Drug Substance Abuse
7. Seattle Drug Detox Center Launches New Program to Help People Stop Dependency on Cocaine, Heroin and Prescription Drugs
8. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Criticism of New Statin Guidelines That Could Result in Millions of New Lipitor Prescriptions
9. US Prescription Drug Market Worth $457.3 Billion by 2021 Says Healthcare Policy Update Report at RnRMarketResearch.com
10. The FDA is Pushing For Greater Restrictions on Prescription Painkillers: Now what?
11. Prescription opioid abusers prefer to get high on oxycodone and hydrocodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Germany, announced it is bringing its product to the United States as part of ... over the last 25 years, Alcovit aims to reduce the productions of nasty toxins ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming ... friends, and community. “Coming Home 2017” will be held on Friday January ...
(Date:1/21/2017)... Austin, Texas (PRWEB) , ... January 21, 2017 ... ... surgeries performed by Austin, Texas Periodontist Dr. Dan Holtzclaw in media for its ... features two surgeries performed by Dr. Holtzclaw in which he utilizes creos™ ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan 20, 2017 Research ... Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, ... By End-use, And Segment Forecasts, 2013 - 2024" report to ... ... 198.5 billion by 2024 Introduction of innovative solutions on ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... to their offering. ... This research service on the global pharmaceutical stability testing market ... of the key participants in the market. The ... 2020. The market is expected to grow at a CAGR of ...
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product ... as Chief Medical Officer. Dr Weinberg will be based in ... ... than 17 years as a pharmaceutical and biotech executive with experience ... course of his career, he has interfaced with the US Food ...
Breaking Medicine Technology: